PT Kimia Farma TbkISX:KAEF 56 Market Cap is Rp2,337,968 Mil as of Jul. 02, 2026. GuruFocus rates ISX:KAEF with a GF Score™ of 56/100 and a GF Value™ of Rp581.83 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 120 Medical Distribution companies, PT Kimia Farma Tbk ranks worse than 52.5% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PT Kimia Farma Tbk's share price for the quarter that ended in Mar. 2026 was Rp462. PT Kimia Farma Tbk's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 5,567 Mil. Therefore, PT Kimia Farma Tbk's market cap for the quarter that ended in Mar. 2026 was Rp2,571,764 Mil.
PT Kimia Farma Tbk's quarterly market cap
declined
from Sep. 2025 (Rp3,005,958 Mil) to Dec. 2025 (Rp2,866,793 Mil) and
declined
from Dec. 2025 (Rp2,866,793 Mil) to Mar. 2026 (Rp2,571,764 Mil).
PT Kimia Farma Tbk's annual market cap
declined
from Dec. 2023 (Rp8,025,530 Mil) to Dec. 2024 (Rp3,367,784 Mil) and
declined
from Dec. 2024 (Rp3,367,784 Mil) to Dec. 2025 (Rp2,866,793 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PT Kimia Farma Tbk's Enterprise Value for Today is Rp9,746,953 Mil.
PT Kimia Farma Tbk (ISX:KAEF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PT Kimia Farma Tbk Market Cap Related Terms
PT Kimia Farma Tbk Market Cap Historical Data
* Premium members only.
The historical data trend for PT Kimia Farma Tbk's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, PT Kimia Farma Tbk's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Kimia Farma Tbk Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's Market Cap distribution charts can be found below:
* The bar in red indicates where PT Kimia Farma Tbk's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PT Kimia Farma Tbk's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kimia Farma Tbk (ISX:KAEF) has a Market Cap of Rp2,337,968 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Kimia Farma Tbk and its competitors. According to the industry distribution chart, PT Kimia Farma Tbk ranks #63 out of 120 companies in the Medical Distribution industry, placing it in the top 52.5%.
Is PT Kimia Farma Tbk's Market Cap too high?
PT Kimia Farma Tbk's current Market Cap is Rp2,337,968 Mil. Based on the distribution chart, PT Kimia Farma Tbk ranks #63 out of 120 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, PT Kimia Farma Tbk has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Tbk's Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, PT Kimia Farma Tbk ranks #63 out of 120 companies for Market Cap. This places PT Kimia Farma Tbk in the lower half of its industry. The industry median Market Cap is 144.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 144.63, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Kimia Farma Tbk and its competitors. For the Medical Distribution industry, the median Market Cap is 144.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Kimia Farma Tbk's current Market Cap is Rp2,337,968 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp581.83, compared to a current price of Rp420.00 — trading 27.8% below its estimated fair value. The current Market Cap is Rp2,337,968 Mil. PT Kimia Farma Tbk's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PT Kimia Farma Tbk (ISX:KAEF), the current Market Cap is Rp2,337,968 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Kimia Farma Tbk (ISX:KAEF) Overvalued in 2026?
Based on GuruFocus' analysis, PT Kimia Farma Tbk stock appears to be undervalued.
The current stock price of Rp420.00 is trading 27.8% below its estimated GF Value™ of Rp581.83.
GuruFocus considers PT Kimia Farma Tbk to be Modestly Undervalued.
Key valuation signals for ISX:KAEF:
Market Cap: Rp2,337,968 Mil
GF Value™: Rp581.83 vs. price of Rp420.00 (27.8% below fair value)
No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
56GF Score
Get the complete analysis for ISX:KAEF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:KAEF has been successfully added to your 
